Page last updated: 2024-08-17

dichloroacetic acid and Multiple Myeloma

dichloroacetic acid has been researched along with Multiple Myeloma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bennett, SK; Blackburn, AC; Coupland, LA; Crispin, P; D'Rozario, J; Forwood, K; Lwin, Y; Neeman, T; Pooryousef, N; Tea, I; Tian, DD; Truong, TT	1
Fujiwara, S; Hata, H; Kawano, Y; Mitsuya, H; Nosaka, K; Okuno, Y; Yuki, H	1

Trials

1 trial(s) available for dichloroacetic acid and Multiple Myeloma

Article	Year
Pharmacology research & perspectives, 2019, Volume: 7, Issue:6 Topics: Administration, Oral; Aged; Dichloroacetic Acid; Drug Resistance, Neoplasm; Drugs, Investigational; Female; Genotype; Glutathione Transferase; Half-Life; Humans; Male; Middle Aged; Multiple Myeloma; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Prospective Studies; Protein Kinase Inhibitors; Pyruvate Dehydrogenase Acetyl-Transferring Kinase	2019

Article

Year

Pharmacology research & perspectives, 2019, Volume: 7, Issue:6

Topics: Administration, Oral; Aged; Dichloroacetic Acid; Drug Resistance, Neoplasm; Drugs, Investigational; Female; Genotype; Glutathione Transferase; Half-Life; Humans; Male; Middle Aged; Multiple Myeloma; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Prospective Studies; Protein Kinase Inhibitors; Pyruvate Dehydrogenase Acetyl-Transferring Kinase

2019

Other Studies

1 other study(ies) available for dichloroacetic acid and Multiple Myeloma

Article	Year
PDK1 inhibition is a novel therapeutic target in multiple myeloma. British journal of cancer, 2013, Jan-15, Volume: 108, Issue:1 Topics: Boronic Acids; Bortezomib; Cell Line, Tumor; Dichloroacetic Acid; Glucose; Glycolysis; Humans; Lactate Dehydrogenases; Lactic Acid; Molecular Targeted Therapy; Multiple Myeloma; Protein Serine-Threonine Kinases; Pyrazines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA, Small Interfering	2013

Article

Year

PDK1 inhibition is a novel therapeutic target in multiple myeloma.

British journal of cancer, 2013, Jan-15, Volume: 108, Issue:1

Topics: Boronic Acids; Bortezomib; Cell Line, Tumor; Dichloroacetic Acid; Glucose; Glycolysis; Humans; Lactate Dehydrogenases; Lactic Acid; Molecular Targeted Therapy; Multiple Myeloma; Protein Serine-Threonine Kinases; Pyrazines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA, Small Interfering

2013